Marijuana: Is it Medicine Yet? (2018-2019)

Overview

This informative and in depth video course presents leading expert and integrative oncologist, Dr. Donald Abrams, presenting on the following topics:

  • Historical Use of Cannabis
  • Cannabis as Medicine
  • Cannabinoid Receptors
  • Cannabidiol (CBD)
  • Medical Application of Cannabis
  • Cannabis and Cancer
  • Supportive Care
  • Safety and Dependency of Cannabis
  • Dosing Medicinal Cannabis

About Dr. Abrams: Donald I. Abrams, M.D. has served as the chief of the Hematology-Oncology Division at San Francisco General Hospital and is a Professor of Clinical Medicine at the University of California San Francisco. He has an Integrative Oncology consultation practice at the UCSF Osher Center for Integrative Medicine.

He was one of the original clinician/investigators to recognize and define many early AIDS-related conditions. He has long been interested in clinical trials of complementary and alternative medicine interventions for HIV/AIDS and cancer, including evaluations of medicinal marijuana, as first inspired by Rick Doblin in 1992. In 1997 he received funding from the National Institute on Drug Abuse to conduct clinical trials of the short-term safety of cannabinoids in HIV infection. Subsequently he was granted funds by the University of California Center for Medicinal Cannabis Research to continue studies of the effectiveness of cannabis in a number of clinical conditions. His last NIDA-funded trial investigated the possible pharmacokinetic interaction between vaporized cannabis and opioid analgesics in patients with chronic pain. He co-authored the chapter on “Cannabinoids and Cancer” in the Oxford University Press Integrative Oncology text that he co-edited with Andrew Weil.

Overall Goals

  • Learn about the elements in cannabis and the mechanism by which they may have medicinal value.
  • Learn about the pharmacokinetic and safety profiles of various cannabis therapies.
  • Learn medical symptoms which may be improved by medical marijuana.

Learning Objectives

Students will be able to:

  • Describe the interaction between cannabinoid receptors, endocannabinoids and phytocannabinoids in the use of medical marijuana.
  • Enumerate three different modes of delivery of cannabis and discuss the different pharmacokinetic and safety profiles.
  • List three symptoms that may be improved by cannabis medicines.

Curriculum

Course Module: Medical Marijuana: Is It Medicine Yet? - Video Lecture

Course Evaluation: Tell us about your experience with the course.

Course Exam: Assessment to ensure knowledge attainment. Passing score of 70% required for continuing education credit and certificate of completion.

Completion Requirements

Complete all the course work, course evaluation, and the final test with a score of 70% or better. Upon successful completion you will be able to print your certificate of completion.

Target Audience

Physicians, physician assistants, and other health practitioners who have interest in integrative medicine.

Enrollment

You will have a maximum of 30 days access to the material from the start date. You can register and start immediately. If you register for the course and pay with a credit card you will have immediate access to the course. Once your registration is complete, logout and log back in and your course will be listed on the campus page. If you cannot remember your account information, click the Get Username and Password link on the login page and it will be emailed to you.

  1. Complete your registration, including payment of the invoice (find this on "My Account")
  2. Log out
  3. Then log back in
  4. If you cannot remember your account information, click the "Get Username and Password" link on the login page and it will be sent to the email address you used to register.
  5. Your course will be listed on the Community Hub page.

Marijuana: Is it Medicine Yet? (2018-2019)
Disclosure & Education Credit Info

COM CME

Physicians

ACCME/AMA PRA Accreditation and CME Designation Statement

The University of Arizona College of Medicine — Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine — Tucson designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This course includes an assessment of 10 questions that you must answer 70% correctly or above in order to receive credit for participation. You are allowed unlimited re-attempts.

Current CME Approval Period: 10/1/2018 to 9/30/2019

Most Recent Review by Author: 08/26/2018

Conflict of Interest Disclosure Information

Dr. Donald Abrams has disclosed that he is a consultant for Abcann, Axim, Maui Grown Therapies, Scriptyx, and Tikum Olam.

All other Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they do not have any relevant financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.

Commercial Support

There is no commercial support for this activity.

Faculty / Authors

Donald I. Abrams, MD; Chief, Hematology-Oncology, Zuckerberg Francisco General Hospital; Professor of Clinical Medicine, UCSF.

Planning Committee

Ann Marie Chiasson, MD, MPH, CCFP; Director, Fellowship in Integrative Medicine, University of Arizona Center for Integrative Medicine.